Literature DB >> 31961069

Tatton-Brown-Rahman syndrome: Six individuals with novel features.

Tugce B Balci1, Alana Strong2, Jennifer M Kalish2, Elaine Zackai2, John M Maris3, Anne Reilly3, Lea F Surrey4, Gerald B Wertheim4, Julien L Marcadier5, Gail E Graham1, Melissa T Carter1.   

Abstract

Tatton-Brown Rahman syndrome (TBRS) is an overgrowth-intellectual disability syndrome caused by heterozygous variants in DNMT3A. Seventy-eight individuals have been reported with a consistent phenotype of somatic overgrowth, mild to moderate intellectual disability, and similar dysmorphisms. We present six individuals with TBRS, including the youngest individual thus far reported, first individual to be diagnosed with tumor testing and two individuals with variants at the Arg882 domain, bringing the total number of reported cases to 82. Patients reported herein have additional clinical features not previously reported in TBRS. One patient had congenital diaphragmatic hernia. One patient carrying the recurrent p.Arg882His DNMT3A variant, who was previously reported as having a phenotype due to a truncating variant in the CLTC gene, developed a ganglioneuroblastoma at 18 months and T-cell lymphoblastic lymphoma at 6 years of age. Four patients manifested symptoms suggestive of autonomic dysfunction, including central sleep apnea, postural orthostatic hypotension, and episodic vasomotor instability in the extremities. We discuss the molecular and clinical findings in our patients with TBRS in context of existing literature.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990DNMT3A; Tatton-Brown Rahman syndrome; dysautonomia; neuroblastoma

Mesh:

Substances:

Year:  2020        PMID: 31961069     DOI: 10.1002/ajmg.a.61475

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults.

Authors:  Margaret A Ferris; Amanda M Smith; Sharon E Heath; Eric J Duncavage; Matthew Oberley; David Freyer; Robert Wynn; Sofia Douzgou; John M Maris; Anne F Reilly; Melinda D Wu; Florence Choo; Roel B Fiets; Saskia Koene; David H Spencer; Christopher A Miller; Marwan Shinawi; Timothy J Ley
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

Review 2.  Germline Abnormalities in DNA Methylation and Histone Modification and Associated Cancer Risk.

Authors:  Jenna A Fernandez; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2022-06-02       Impact factor: 4.213

Review 3.  Regulation, functions and transmission of bivalent chromatin during mammalian development.

Authors:  Trisha A Macrae; Julie Fothergill-Robinson; Miguel Ramalho-Santos
Journal:  Nat Rev Mol Cell Biol       Date:  2022-08-26       Impact factor: 113.915

4.  Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome.

Authors:  Alana C Cecchi; Amier Haidar; Isabella Marin; Callie S Kwartler; Siddharth K Prakash; Dianna M Milewicz
Journal:  Am J Med Genet A       Date:  2021-10-13       Impact factor: 2.578

5.  Case Report: The success of face analysis technology in extremely rare genetic diseases in Korea: Tatton-Brown-Rahman syndrome and Say-Barber -Biesecker-Young-Simpson variant of ohdo syndrome.

Authors:  Sunha Park; Jaewon Kim; Tae-Young Song; Dae-Hyun Jang
Journal:  Front Genet       Date:  2022-08-03       Impact factor: 4.772

6.  Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome.

Authors:  Amanda M Smith; Taylor A LaValle; Marwan Shinawi; Sai M Ramakrishnan; Haley J Abel; Cheryl A Hill; Nicole M Kirkland; Michael P Rettig; Nichole M Helton; Sharon E Heath; Francesca Ferraro; David Y Chen; Sangeeta Adak; Clay F Semenkovich; Diana L Christian; Jenna R Martin; Harrison W Gabel; Christopher A Miller; Timothy J Ley
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.